# V98 Independent Phase1141 — Y official frozen 90-cell economic rejection

**Date:** 2026-10-23. **Official GitHub Actions run:** https://github.com/DnSiii/CryptoAI-Lab/actions/runs/39986664898. **Pre-economic full freeze:** Phase1137, commit ad6d5a0135fc07ca9ed70c8d39d8d9796d4194c1. **Decision: REJECT_Y_TRAINING_NO_RESCUE.** Y remains immutable and is not a current economic champion.

## Source, scope and integrity

Fresh official Clean-4 source attestation PASS (18,288 hourly bars; 9,144 native funding events; signed mark shape [18288,4,2]; five canonical target hashes fixed before historical PnL). No 2025 validation, 2026+, XRP, contaminated Phase083 holdout, or V14/V15/V99 signals/benchmarks were read. The full 90-cell training grid is exactly five paths x three cost tiers x two funding orderings x three capital modes; no selection or parameter adjustment after seeing results. Synthetic Phase1135/1136/1138 tests passed 37/37 on both Ubuntu 22.04 and 24.04; Phase1140 independent receipt consistency tests passed 5/5.

## Official outcomes

**90/90 cells attempted; 18/90 survived and 72/90 rejected.** Rejection reasons: 60 Y1126_OPEN_CAPACITY, 6 Y1126_INTRABAR_ASSET, 6 Y1126_INTRABAR_NET. By path: Y_core_only 0/18; Y_full 6/18; Y_minus_opportunity 6/18; Y_minus_relative_value 0/18; Y_minus_stress 6/18. All $1m and $10m capital cells failed quote capacity; surviving cells were only $10k. First $10m capacity failure: 2023-01-01 01:00 UTC (hour 745); first $1m capacity failure: 2023-01-01 13:00 UTC (hour 757). Core-only net cap breach: 2023-01-14 00:00 UTC (hour 1056). Minus-relative-value asset cap breach: 2024-02-12 15:00 UTC (hour 10527).

**Y_full, $10k, base fee .0007, carried-before-fill:** 2023 CAGR **-71.23%**, 2024 CAGR **-79.71%**, two-year log wealth **-2.8431**, maximum hourly drawdown **-94.64%**. Other funding ordering produced nearly identical negative returns. Severe tier: 2023 -75.40%, 2024 -83.06%, max drawdown -96.15%. Supersevere tier: 2023 -80.87%, 2024 -87.31%, max drawdown -97.73%. These are authentic historical *training* measurements for the survived cells, NOT validated future returns or a live trading claim.

**Marginal contribution:** at $10k/base/carried-before-fill, Y_minus_opportunity (2023 -65.30%, 2024 -77.93%) outperformed Y_full (-71.23%, -79.71%); opportunity marginal contribution is negative. Y_minus_stress had -72.43% / -80.49%; stress contribution is modestly positive in this cell, but Y_full remains deeply unprofitable. No cherry-picking: 72 failed cells do not get CAGR or favorable replacement metrics.

## Independent consistency and irreversible decision

The official Phase1138 growth audit reports `REJECT_Y_TRAINING_NO_RESCUE`, `cells_observed=90`, `cells_survived=18`, and `growth_gate_evaluated=false` because the 90/90 survival prerequisite failed. An independent read-only Phase1140-equivalent check of the 18 surviving receipts found **0 wealth/regime/fold/risk/fee consistency errors**; this does not rescue Y.

**Y is economically rejected, frozen, not eligible for 2025 validation or external benchmark comparison.** Do not change Y signs, windows, costs, risk caps, execution, frozen source hashes, or report selection to rescue the result. Distinct Z architecture preregistered separately in Phase1142 with capital-mode-native portfolio optimization and different four sleeves. Next: implement Z's seven-slot source and independent synthetic survival, then source lock, pre-economic freeze and chronological training.
